<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">

  <link rel="icon" type="image/x-icon" href="favicon.ico"/>
  <link rel="shortcut icon" href="favicon.ico" />
  <link rel="icon" sizes="16x16" href="assets/favicon-16x16.png" />
  <link rel="icon" sizes="32x32" href="assets/favicon-32x32.png" />
  <link rel="icon" sizes="192x192" href="assets/android-chrome-192x192.png" />
  <link rel="apple-touch-icon" sizes="180x180" href="assets/apple-touch-icon.png" />

  <meta name="description" content="Some page description" />
  <meta property="og:site_name" content="Epikast" />

  <meta property="og:title" content="Epikast page title" />
  <meta property="og:description" content="Page description" />
  <meta name="keywords" content="patients, prescribers, caregivers, data, insights">
  <meta property="og:image" content="assess/og_img.png" />

  <link rel="stylesheet" href="css/layout/layout.css">
  <link rel="stylesheet" href="css/pages/about.css">

  <title>About us</title>
</head>
<body>

  <header>
    <div class="container container--header">
      <a href="index.html" class="logo">
        <figure>
          <img src="assets/logo.svg" alt="Epikast logo" width="158" height="36">
        </figure>
      </a>
      <nav class="menu-wrap js-menu">
        <ul class="menu">
          <li><a href="services.html">Our services</a></li>
          <li><a href="about.html" class="active">About us</a></li>
          <li><a href="careers.html">Careers</a></li>
          <li><a href="contact.html">Contact us</a></li>
        </ul>
      </nav>
      <span class="burger js-burger"></span>
    </div>
  </header>

  <main class="container container--main">
    
    <section class="quotes">
      <article class="split split--double quote">
        <div class="split__part quote__content">
          Redefine how biopharmaceutical companies engage with 
          their most important stakeholders:
          <strong>patients / caregivers and prescribers.</strong>
        </div>
        <figure class="split__part rounded layered">
          <img src="assets/images/about_1.png" width="576" height="400" />
        </figure>
      </article>
      <article class="split split--double quote">
        <figure class="split__part rounded layered">
          <img src="assets/images/about_2.png" width="576" height="400" />
        </figure>
        <div class="split__part quote__content">
          We focus on collecting and synthesizing all appropriate 
          <strong>data</strong> from those interactions, enabling our partners to 
          gain <strong>unique insights</strong> into the use of their medications 
          in the real world.
        </div>
      </article>
    </section>

    <section class="values bubble">
      <h2 class="bubble__title">Our values</h2>
      <div class="values__wrap js-values">
        <ul class="split split--double values__list">
          <li class="split__part values__item">
            <h3 class="value__title">
              <img src="assets/Care.svg" width="40" height="40" alt="Care" /> Care
            </h3>
            <div class="content">
              We care deeply for the patients we serve. 
              Everything we do is aimed towards improving their lives.
            </div>
          </li>
          <li class="split__part values__item">
            <h3 class="value__title">
              <img src="assets/Excellence.svg" width="40" height="40" alt="Excellence" /> Excellence
            </h3>
            <div class="content">
              Simply put, we never compromise. We strive for excellence 
              in everything we do, and we continuously learn from our 
              customers and from each other.
            </div>
          </li>
          <li class="split__part values__item">
            <h3 class="value__title">
              <img src="assets/Innovation.svg" width="40" height="40" alt="Innovation" /> Innovation
            </h3>
            <div class="content">
              We don’t ask how things have been done in the past, 
              but how they should be done in 10 years from now. 
              We live and breathe technology and data,
              while maintaining our core of a human-centric business.
            </div>
          </li>
          <li class="split__part values__item">
            <h3 class="value__title">
              <img src="assets/Integrity.svg" width="40" height="40" alt="Integrity" /> Integrity
            </h3>
            <div class="content">
              We do not overpromise to our customers, we do not bend 
              any rules ever, and we treat our stakeholders – patients, 
              physicians, customers, employees, and our communities – 
              exactly how we would want to be treated. When we give our 
              word, we stick to it.
            </div>
          </li>
        </ul>
        <div class="pagination pagination--values"></div>
      </div>
      <img src="assets/element_3.svg" class="values__element">
    </section>

    <section class="personas">
      <h2 class="personas__title">Our board and leadership team</h2>
      <div class="personas__wrap js-personas">
        <div class="split split--quadraple">
          <article class="split__part persona">
            <div class="persona__card">
              <figure class="persona__image">
                <img src="assets/images/Vangelis_vergetis.png" width="152" height="160" alt="Vangelis Vergetis" />
              </figure>
              <h3 class="persona__title">Vangelis Vergetis, PhD</h3>
              <div class="persona__desc">CEO and board member</div>
              <img class="persona__arrow" src="assets/arrow.svg">
            </div>
            <div class="persona__bio-wrap">
              <div class="persona__bio">
                <img class="persona__close" src="assets/close.svg" alt="">
                <div class="persona__content content">
                  <p>
                    Vangelis has been working in the intersection 
                    of healthcare, technology, and data science 
                    for more than 15 years.
                  </p>
                  <p>
                    He spent about a dozen 
                    years as a consultant at McKinsey and at Hakluyt, 
                    working with biopharmaceutical companies on several 
                    topics – particularly in launching drugs across 
                    disease areas, and in designing and putting in 
                    place their commercial models and infrastructure. 
                  </p>
                  <p>
                    Immediately prior to Epikast, Vangelis was the 
                    co-founder and CEO of Intelligencia, a software 
                    company that utilizes AI to assess and reduce 
                    the risk of clinical trials.
                  </p>
                  <p>
                    He is a board member and member of the executive committee 
                    at the Alliance for AI in Healthcare (AAIH), 
                    and a former member of the advisory board for 
                    Cornell’s department of Computer &amp; 
                    Information Science (CIS).
                  </p>
                  <p>
                    Vangelis holds a 
                    PhD in Electrical Engineering from the University 
                    of Pennsylvania, and a BS in 
                    Computer Science from Cornell.
                  </p>
                </div>
                <a href="https://www.linkedin.com/in/vangelisvergetis" target="_blank" class="linkedin">
                  <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40">
                    <g id="Group_330" data-name="Group 330" fill="#fff">
                      <path id="Path_177" data-name="Path 177" class="cls-1" d="m13.27,31.23h-5.06V15.17h4.97v16.06h.09Zm-2.53-18.21c-1.6-.09-2.82-1.46-2.73-3.06.08-1.47,1.26-2.65,2.73-2.73,1.6.09,2.82,1.46,2.73,3.06-.08,1.47-1.26,2.65-2.73,2.73Zm21.25,18.21h-4.96v-7.83c0-1.87,0-4.3-2.62-4.3s-2.99,2.09-2.99,4.11v7.94h-5.05v-15.99h4.78v2.15h.1c.98-1.69,2.81-2.7,4.77-2.62,5.06,0,6,3.36,6,7.66v8.87h-.01Z"/>
                    </g>
                  </svg>
                </a>
              </div>
            </div>
          </article>
          <article class="split__part persona">
            <div class="persona__card">
              <figure class="persona__image">
                <img src="assets/images/Stelios_papadopoulos.png" width="152" height="160" alt="Stelios Papadopoulos" />
              </figure>
              <h3 class="persona__title">Stelios Papadopoulos, PhD</h3>
              <div class="persona__desc">Chairman of the board</div>
              <img class="persona__arrow" src="assets/arrow.svg" alt="">
            </div>
            <div class="persona__bio-wrap">
              <div class="persona__bio">
                <img class="persona__close" src="assets/close.svg" alt="">
                <div class="persona__content content">
                  <p>
                    Stelios brings more than four decades 
                    of experience in the biopharmaceutical 
                    industry in various roles: as a company 
                    founder, executive, investment banker, and 
                    leader in the global healthcare sector.
                  </p>
                  <p>
                    He serves as the chairman of the board of 
                    directors of Biogen Inc., a global biotechnology company, 
                    Exelixis, Inc., a drug discovery and development 
                    company that he co-founded in 1994, Regulus Therapeutics, 
                    Inc., a biopharmaceutical company, and Eucrates 
                    Biomedical Acquisition Corp., a special purpose 
                    acquisition company.  He co-founded Anadys 
                    Pharmaceuticals, Inc., a biopharmaceutical company, 
                    in 2000 and was a member of its board of directors 
                    until its acquisition by Hoffman-La Roche in 2011, 
                    serving as the chairman of the board during 2011.
                  </p>
                  <p>
                    In the not-for-profit sector, Stelios is a co-founder 
                    and chairman of FondationSanté, a member of the Board 
                    of Visitors of Duke Medicine and a member of the Global 
                    Advisory Board of the Duke Institute for Health Innovation.
                  </p>
                  <p>
                    He retired as Vice Chairman of Cowen & Co., LLC, a financial 
                    services company, in 2006, after six years with the firm where, 
                    as an investment banker, he focused on the biotechnology and 
                    pharmaceutical sectors. Prior to joining Cowen, he spent 13 
                    years as an investment banker at PaineWebber, Inc., where 
                    he was most recently Chairman of PaineWebber Development Corp., 
                    a PaineWebber subsidiary focusing on biotechnology. 
                    He joined PaineWebber in 1987 from Drexel Burnham Lambert 
                    where, as an analyst in the Equity Research Department, 
                    he covered the biotechnology industry. Prior to Drexel, 
                    he was the biotechnology analyst of Donaldson, Lufkin & Jenrette.
                  </p>
                  <p>
                    Before coming to Wall Street, Stelios was on the faculty of the 
                    Department of Cell Biology at New York University School of Medicine. 
                    He maintains his affiliation with NYU as an adjunct associate 
                    professor of cell biology.
                  </p>
                </div>
              </div>
            </div>
          </article>
          <article class="split__part persona">
            <div class="persona__card">
              <figure class="persona__image">
                <img src="assets/images/Dimitris_Papalexopoulos.png" width="152" height="160" alt="Dimitris Papalexopoulos" />
              </figure>
              <h3 class="persona__title">Dimitris Papalexopoulos</h3>
              <div class="persona__desc">Board member</div>
              <img class="persona__arrow" src="assets/arrow.svg" alt="">
            </div>
            <div class="persona__bio-wrap">
              <div class="persona__bio">
                <img class="persona__close" src="assets/close.svg" alt="">
                <div class="persona__content content">
                  <p>
                    Dimitri is Chairmanof Titan Cement Group, a cement 
                    and building materials producer active since 1902. 
                    The group directly employs about 5,500 people, 
                    operates cement plants in 10 countries and is 
                    active in many more. Prior to joining Titan in 1989, 
                    Dimirtistarted his career as a business consultant 
                    for McKinsey & Company Inc. in the USA and Germany. 
                    He is Chairman of the Board of the Hellenic Federation 
                    of Enterprises (SEV), Vice-Chairman of the European 
                    Round Table for Industry (ERT) and chairs the ERT’s 
                    Energy Transition & Climate Change Committee. 
                    He is a member of the Board of the Foundation for 
                    Economic and Industrial Research (IOBE), the 
                    Hellenic Foundation for European and Foreign Policy 
                    (ELIAMEP) and of Endeavor Greece. He holds a M.Sc. 
                    in Electrical Engineering from the Swiss Federal 
                    Institute of Technology (ETHZ) and an MBA 
                    from Harvard Business School.
                  </p>
                </div>
              </div>
            </div>
          </article>
          <article class="split__part persona">
            <div class="persona__card">
              <figure class="persona__image">
                <img src="assets/images/Mike Krzan.png" width="152" height="160" alt="Mike Krzan" />
              </figure>
              <h3 class="persona__title">Mike Krzan</h3>
              <div class="persona__desc">Advisor</div>
              <img class="persona__arrow" src="assets/arrow.svg" alt="">
            </div>
            <div class="persona__bio-wrap">
              <div class="persona__bio">
                <img class="persona__close" src="assets/close.svg" alt="">
                <div class="persona__content content">
                  <p>
                    Mike brings a lifetime of experience in building and 
                    running high-performing patient services organizations, 
                    having spent more than 20 years in the space. He led 
                    Biogen’s patient services center in North Carolina 
                    for more than a decade, and prior to that was a SVP 
                    for member services and pharmacy operations at Medco. 
                    While at Biogen, Mike was a member of the US Senior 
                    Leadership Team, developed and set the direction for 
                    the patient services organization to support $8B of 
                    revenue, launched seven products (including a blockbuster 
                    drug and an orphan drug), and collaborated with 
                    field sales leaders to identify trends, define 
                    tactics for improved performance, and ensure national 
                    team alignment. He holds a BS in Pharmacy 
                    from Duquesne University.
                  </p>
                </div>
                <a href="https://www.linkedin.com/in/mike-krzan" target="_blank" class="linkedin">
                  <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40">
                    <g id="Group_330" data-name="Group 330" fill="#fff">
                      <path id="Path_177" data-name="Path 177" class="cls-1" d="m13.27,31.23h-5.06V15.17h4.97v16.06h.09Zm-2.53-18.21c-1.6-.09-2.82-1.46-2.73-3.06.08-1.47,1.26-2.65,2.73-2.73,1.6.09,2.82,1.46,2.73,3.06-.08,1.47-1.26,2.65-2.73,2.73Zm21.25,18.21h-4.96v-7.83c0-1.87,0-4.3-2.62-4.3s-2.99,2.09-2.99,4.11v7.94h-5.05v-15.99h4.78v2.15h.1c.98-1.69,2.81-2.7,4.77-2.62,5.06,0,6,3.36,6,7.66v8.87h-.01Z"/>
                    </g>
                  </svg>
                </a>
              </div>
            </div>
          </article>
        </div>
      </div>
    </section>

  </main>

  <footer class="container container--footer">
    <a href="https://www.linkedin.com/company/epikast/" target="_blank" aria-label="Linkedin" class="linkedin">
      <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40">
        <g id="Group_330" data-name="Group 330" fill="#000033">
          <path id="Path_177" data-name="Path 177" class="cls-1" d="m13.27,31.23h-5.06V15.17h4.97v16.06h.09Zm-2.53-18.21c-1.6-.09-2.82-1.46-2.73-3.06.08-1.47,1.26-2.65,2.73-2.73,1.6.09,2.82,1.46,2.73,3.06-.08,1.47-1.26,2.65-2.73,2.73Zm21.25,18.21h-4.96v-7.83c0-1.87,0-4.3-2.62-4.3s-2.99,2.09-2.99,4.11v7.94h-5.05v-15.99h4.78v2.15h.1c.98-1.69,2.81-2.7,4.77-2.62,5.06,0,6,3.36,6,7.66v8.87h-.01Z"/>
        </g>
      </svg>
    </a>
    <div class="mail-copy">
      <span class="js-copy-year"></span> &copy; All rights reserved
    </div>
    <a href="index.html" class="logo"><img src="assets/logo.svg" alt="Epikast logo" width="128" height="27"/></a>
  </footer>
  
  <script src="js/swiper.min.js"></script>
  <script src="js/global.js"></script>
</body>
</html>